ASP Isotopes Inc. (ASPI)
NASDAQ: ASPI · IEX Real-Time Price · USD
4.095
-0.205 (-4.77%)
Mar 28, 2024, 2:22 PM EDT - Market open
ASP Isotopes Market Cap
ASP Isotopes has a market cap or net worth of $208.26 million as of March 28, 2024. Its market cap has increased by 438.14% in one year.
Market Cap
208.26M
Enterprise Value
206.69M
1-Year Change
438.14%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since the IPO on November 10, 2022, ASP Isotopes's market cap has increased from $126.43M to $208.26M, an increase of 64.73%. That is a compound annual growth rate of 43.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 209.70M | -1.83% |
Mar 26, 2024 | 213.60M | -2.69% |
Mar 25, 2024 | 219.50M | -3.00% |
Mar 22, 2024 | 226.30M | -3.54% |
Mar 21, 2024 | 234.60M | 5.25% |
Mar 20, 2024 | 222.90M | 2.48% |
Mar 19, 2024 | 217.50M | -4.52% |
Mar 18, 2024 | 227.80M | 15.87% |
Mar 15, 2024 | 196.60M | 6.10% |
Mar 14, 2024 | 185.30M | -5.02% |
Mar 13, 2024 | 195.10M | 0.77% |
Mar 12, 2024 | 193.60M | 9.38% |
Mar 11, 2024 | 177.00M | 4.86% |
Mar 8, 2024 | 168.80M | -3.32% |
Mar 7, 2024 | 174.60M | - |
Mar 6, 2024 | 174.60M | 6.53% |
Mar 5, 2024 | 163.90M | -2.61% |
Mar 4, 2024 | 168.30M | -10.14% |
Mar 1, 2024 | 187.30M | 0.81% |
Feb 29, 2024 | 185.80M | 19.41% |
Feb 28, 2024 | 155.60M | -7.27% |
Feb 27, 2024 | 167.80M | -15.68% |
Feb 26, 2024 | 199.00M | 7.39% |
Feb 23, 2024 | 185.30M | -5.02% |
Feb 22, 2024 | 195.10M | 29.03% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lineage Cell Therapeutics | 236.61M |
Pyxis Oncology | 231.95M |
Agenus | 228.77M |
XBiotech | 228.08M |
Mesoblast | 227.45M |
Ovid Therapeutics | 226.27M |
Vanda Pharmaceuticals | 223.82M |
Zevra Therapeutics | 221.00M |